[14/03/2008] Press conference 14 March 2008 (11:00 CET)
The presentation used at the press conference of 14 March 2008 (11:00 CET) can be downloaded here.
Highlights
- Marc Coucke accepts mission as CEO. Lucas Laureys appointed Chairman of the Board. Jan Cassiman becomes COO.
- Key figures: 16% EBITDA margin (before non-recurring items) -- 154.8 miljoen net result of the group
- Successful Arseus IPO yields considerable plus-value.
- Strengthened balance sheet structure
- Omega Pharma holds today 7.4% treasury shares
- Proposal for a gross dividend of 0.50 euro per share
- The anti-snoring product Silence is the newest Star Brand.
Press release
Condensed consolidated financial statement
Profile Lucas Laureys
13 March 2008 - 17:45 CET
[Back to archive]
